Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,463,444
-$2,101,305 QoQ
Shares Held
32,484
-4.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#239
of 665 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Utah Retirement Systems holds $63,005,640 across 24 Biotechnology names. INSM ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,602 | $19,174,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,346 | $9,568,844 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,236 | $6,091,643 | |
| 4 | MRNA |
Moderna, Inc.
|
55,289 | $3,871,888 | |
| 5 | RPRX |
Royalty Pharma plc
|
62,812 | $3,521,868 | |
| 6 | INSM |
INSMED Inc
This page
|
32,484 | $3,463,444 | |
| 7 | INCY |
Incyte Corp
|
25,159 | $2,852,024 | |
| 8 | EXEL |
Exelixis, Inc.
|
37,844 | $2,059,092 |
All Filings in INSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,463,444 | 32,484 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,564,749 | 34,031 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,569,454 | 32,001 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,425,283 | 30,729 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $949,639 | 9,436 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||